Catalyst Wire Dossier Catalyst Wire Dossier

BRILINTA

ticagrelor · AstraZeneca Pharmaceuticals LP
Drug timelines are a Plus or Pro feature.

95 regulatory and trial events tracked for BRILINTA, covering 2011-07-20 to 2025-09-02. Get the full timeline:

Most recent: Clinical Trial Update: Ticagrelor and ASA vs. ASA Only After Isolated Coronary Artery Bypass Grafting in Patients With Acute Coronary Syndrome [Phase 4]

See pricing